Cargando…
In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing Enterobacter cloacae and Klebsiella pneumoniae in Murine Pneumonia Model
Carbapenem-resistant Enterobacterales (CRE) and carbapenemase-producing Enterobacterales (CPE) have become global threats. CRE− and CPE− derived infections have been associated with high mortality due to limited treatment options. Nacubactam is a β-lactamase inhibitor and belongs to the new class of...
Autores principales: | Hagihara, Mao, Kato, Hideo, Sugano, Toshie, Okade, Hayato, Sato, Nobuo, Shibata, Yuichi, Sakanashi, Daisuke, Hirai, Jun, Asai, Nobuhiro, Suematsu, Hiroyuki, Yamagishi, Yuka, Mikamo, Hiroshige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532682/ https://www.ncbi.nlm.nih.gov/pubmed/34680760 http://dx.doi.org/10.3390/antibiotics10101179 |
Ejemplares similares
-
A Large Gap in Patients’ Characteristics and Outcomes between the Real-World and Clinical Trial Settings in Community-Acquired Pneumonia and Healthcare-Associated Pneumonia
por: Asai, Nobuhiro, et al.
Publicado: (2022) -
Secondary organizing pneumonia following viral pneumonia caused by severe influenza B: a case report and literature reviews
por: Asai, Nobuhiro, et al.
Publicado: (2017) -
Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review
por: Sugimoto, Naomi, et al.
Publicado: (2017) -
1279. In Vitro Activity of Nacubactam (OP0595) Alone and in Combination with β-Lactams against β-Lactamase-Producing Enterobacterales Isolated in Japan
por: Nagira, Yu, et al.
Publicado: (2020) -
Development of an optimized and practical pharmacokinetics/pharmacodynamics analysis method for aztreonam/nacubactam against carbapenemase-producing K. pneumoniae
por: Igarashi, Yuki, et al.
Publicado: (2023)